Skip to content

Evaluation the effect of intraoperative administration of magnesium sulfate on post operative pain of patients undergoing general anesthesia for inguinal hernioraphy

Evaluation the effect of intraoperative administration of magnesium sulfate on post operative pain of patient undergoing general anesthesia for inguinal hernioraphy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012102811294N1
Enrollment
30
Registered
2013-01-16
Start date
2012-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain. Acute pain

Interventions

Intervention 1: infusion of magnesium sulphate 40 miligram per kilogram before induction and then 15 miligram per kilogram per hour infusion during the operation until the 20 min after the end of sur
Treatment - Drugs
infusion of magnesium sulphate 40 miligram per kilogram before induction and then 15 miligram per kilogram per hour infusion during the operation until the 20 min after the end of surgery
Infusion of isotonic saline 100 mililitre before induction and then 100 mililitre per hour infusion during the operation until the 20 min after the end of surgery

Sponsors

Vice chancellor for research of Ahvaz Jondishapour University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with ASA 1 or 2 ; the patients without history of drug abuse ; without sensitivity to magnesium , opioids and analgesics ; any hepatic, renal, cardiovascular, neuromascular or neurological disorder ; not to use calcium channel blockers Exclusion criteria: patients with preoperative hemodynamic instability ; preoperative respiratory distress; preoperative nausea and vomiting or any important adverse effects ; patients with magnesium infusion time less than one hour and more than 3 hours.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: 30 min , 2 hours, 6 hours, 12 hours, 24 hours after surgery. Method of measurement: Visual analogue scale.

Secondary

MeasureTime frame
Meperidine consumption. Timepoint: in 24 hours after surgery. Method of measurement: milligramms.;Incidence of adverse effects. Timepoint: In 24 hours after surgery. Method of measurement: Asking from patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Alizadeh

Ahvaz Jondishapour University of Medical Sciences

alizadeh.md6010@yahoo.com+98 61 1222 0168

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026